GERRESHEIMER AG
Commented by Armin Schulz on September 30th, 2025 | 07:00 CEST
What is happening at Gerresheimer? Almonty Industries and Rheinmetall are booming again!
In uncertain times, the focus shifts to companies that form the backbone of our critical infrastructure. Their ability to build resilient and transparent supply chains for essential goods determines our collective resilience to geopolitical and economic upheavals. Where the highest quality and safety standards prevail in areas such as pharmaceuticals, high tech, and defense, sustainable and ethical conduct becomes a decisive competitive advantage, while strict traceability along the value chain becomes the new benchmark. This development makes values such as those of Gerresheimer, Almonty Industries, and Rheinmetall particularly interesting.
Read
Commented by Carsten Mainitz on September 26th, 2025 | 07:35 CEST
Gerresheimer, dynaCERT, Volkswagen – Exciting developments!
News drives prices. However, the pendulum can swing in both directions. For informed investors, the correct interpretation of events is crucial. Often, this then leads to lucrative entry and exit signals. Gerresheimer was the latest to be hit, but which stock could be next? However, there are also stocks that are due for a realignment, offering opportunities for rising prices.
Read
Commented by André Will-Laudien on June 4th, 2025 | 07:00 CEST
With gold over USD 3,400 - 100% gains in no time: Gerresheimer, Desert Gold, Hensoldt, and RENK
Rumors about Jerome Powell's resignation were circulating at the beginning of the week. Described as very "hawkish," meaning he strictly aligns interest rates with inflation, he is an uncomfortable contemporary for President Donald Trump. The US administration needs a lot of money to get the outdated infrastructure and the entire economy back on track. Numerous campaign promises for a flourishing America can only be fulfilled by the flamboyant frontman if sufficient funds are available. This is a difficult undertaking due to the very high level of government debt. The credit rating agency Moody's is not intimidated by the president's threats and recently downgraded the US credit rating by one notch to AA1. Triple-A status is now history. This is a perfect setup for gold, with the precious metal rising again to over USD 3,400. Where are the opportunities for investors?
Read
Commented by Juliane Zielonka on October 3rd, 2024 | 14:00 CEST
Vidac Pharma, BioNTech, Gerresheimer optimize the value chain - From research to patient
Medical innovation and rapid therapy development are gaining momentum thanks to the use of AI. In this context, companies in the pharmaceutical and biotech industry are relying on groundbreaking technologies and strategies to optimize the value chain from research to patient. Vidac Pharma is researching an innovative approach to fighting cancer by supporting the body's own immune defenses. The Company has now received a patent in the US, granting exclusivity. BioNTech is using AI-powered research to bring innovative therapies to patients more quickly. Gerresheimer is producing advanced packaging solutions for pharmaceuticals that have the potential to improve healthcare significantly. We take a look at current annual reports and value chains.
Read